HEADER CATALYTIC ANTIBODY 24-MAR-99 1CF8 TITLE CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: TITLE 2 POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (CATALYTIC ANTIBODY 19A4 (LIGHT CHAIN)); COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB, VARIABLE REGION; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROTEIN (CATALYTIC ANTIBODY 19A4 (HEAVY CHAIN)); COMPND 7 CHAIN: H; COMPND 8 FRAGMENT: FAB, VARIABLE REGION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: 129G1X+/BOY; SOURCE 6 CELL_LINE: 129G1X+(MOUSE)/P3X63AG8.653 (MYELOMA); SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 10 ORGANISM_TAXID: 10090; SOURCE 11 STRAIN: 129G1X+/BOY; SOURCE 12 CELL_LINE: 129G1X+(MOUSE)/P3X63AG8.653 (MYELOMA) KEYWDS CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION KEYWDS 2 CASCADE EXPDTA X-RAY DIFFRACTION AUTHOR C.M.PASCHALL,J.HASSERODT,T.JONES,R.A.LERNER,K.D.JANDA, AUTHOR 2 D.W.CHRISTIANSON REVDAT 6 09-AUG-23 1CF8 1 REMARK LINK REVDAT 5 13-JUL-11 1CF8 1 VERSN REVDAT 4 24-FEB-09 1CF8 1 VERSN REVDAT 3 24-MAY-05 1CF8 1 COMPND REVDAT JRNL REMARK REVDAT 3 2 1 HETNAM FORMUL LINK SITE REVDAT 3 3 1 CRYST1 MASTER REVDAT 2 07-SEP-99 1CF8 1 LINK REVDAT 1 28-JUL-99 1CF8 0 JRNL AUTH C.M.PASCHALL,J.HASSERODT,T.JONES,R.A.LERNER,K.D.JANDA, JRNL AUTH 2 D.W.CHRISTIANSON JRNL TITL CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE JRNL TITL 2 MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI JRNL TITL 3 INTERACTIONS JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 38 1743 1999 JRNL REFN ISSN 1433-7851 JRNL DOI 10.1002/(SICI)1521-3773(19990614)38:12<1743::AID-ANIE1743>3. JRNL DOI 2 0.CO;2-3 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 10933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 597 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.62 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1039 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 73 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3302 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.470 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARHAP.PRO REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPHAP.PRO REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAR-99. REMARK 100 THE DEPOSITION ID IS D_1000000714. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 300.00 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11531 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 3.240 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.3100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.17300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1YEF REMARK 200 REMARK 200 REMARK: USED MODEL OF SEQUENCE WITH ONLY VARYING RESIDUES CHANGED REMARK 200 TO ALANINE. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROP: 11.4 MG/ML FAB, 10MM CDCL2, 50 REMARK 280 MM TRIS, PH 7.0, RESERVOIR: 30% PEG 6000, 100 MM HEPES PH 7.9, REMARK 280 PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.65000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.65000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -28.53064 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 63.48356 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION REMARK 400 OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR L 51 -51.22 69.22 REMARK 500 SER L 67 153.32 174.10 REMARK 500 ALA L 84 -174.31 -174.67 REMARK 500 SER L 176 111.53 -160.67 REMARK 500 THR L 200 -108.75 -68.19 REMARK 500 GLU L 213 -24.37 65.80 REMARK 500 VAL H 2 90.12 46.20 REMARK 500 TYR H 27 128.61 -172.41 REMARK 500 TYR H 33 156.83 68.33 REMARK 500 ASN H 43 1.29 85.34 REMARK 500 LYS H 64 -105.86 -21.69 REMARK 500 SER H 82B 58.70 33.72 REMARK 500 THR H 131 -48.68 70.48 REMARK 500 THR H 132 87.94 69.62 REMARK 500 PHE H 146 143.65 -176.71 REMARK 500 SER H 149 85.68 110.44 REMARK 500 SER H 172 47.06 73.12 REMARK 500 PRO H 189 33.90 -97.55 REMARK 500 ASP H 214 -133.41 -101.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD H1000 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU L 81 OE2 REMARK 620 2 ASP H 173 OD2 79.0 REMARK 620 3 ASP H 173 OD1 108.3 48.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD L1001 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU L 187 OE1 REMARK 620 2 GLU L 213 OE2 111.6 REMARK 620 3 GLU L 213 OE1 129.5 50.6 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: DC1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THIS IS A FULL OCCUPANCY CD2+ SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: DC2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THIS IS A PARTIAL OCCUPANCY CD2+ SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CD H 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CD L 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HAZ H 800 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROPER SEQUENCE DATABASE REFERENCE NOT AVAILABE REMARK 999 DUE TO FRAGMENTS OF VARIABLE REGION DBREF 1CF8 L 1 214 PDB 1CF8 1CF8 1 214 DBREF 1CF8 H 1 215 PDB 1CF8 1CF8 1 215 SEQRES 1 L 215 ASP ILE VAL LEU THR GLN SER PRO THR ILE MET SER VAL SEQRES 2 L 215 SER PRO GLY GLU LYS VAL THR LEU THR CYS SER ALA SER SEQRES 3 L 215 SER SER VAL SER SER ASN TYR VAL TYR TRP TYR GLN GLN SEQRES 4 L 215 LYS PRO GLY SER SER PRO LYS VAL TRP ILE TYR SER THR SEQRES 5 L 215 SER ASN LEU ALA SER GLY VAL PRO ALA ARG PHE SER GLY SEQRES 6 L 215 SER GLY SER GLY THR SER TYR SER LEU THR ILE SER SER SEQRES 7 L 215 MET GLU ALA GLU ASP ALA ALA SER TYR PHE CYS LEU GLN SEQRES 8 L 215 TRP SER SER PHE PRO TYR THR PHE GLY GLY GLY THR LYS SEQRES 9 L 215 LEU GLU LEU LYS ARG ALA ASP VAL ALA PRO THR VAL SER SEQRES 10 L 215 ILE PHE PRO PRO SER SER GLU GLN LEU THR SER GLY GLY SEQRES 11 L 215 ALA SER VAL VAL CYS PHE LEU ASN ASN PHE TYR PRO LYS SEQRES 12 L 215 ASP ILE ASN VAL LYS TRP LYS ILE ASP GLY SER GLU ARG SEQRES 13 L 215 GLN ASN GLY VAL LEU ASN SER TRP THR ASP GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER MET SER SER THR LEU THR LEU SEQRES 15 L 215 THR LYS ASP GLU TYR GLU ARG HIS ASN SER TYR THR CYS SEQRES 16 L 215 GLU ALA THR HIS LYS THR SER THR SER PRO ILE VAL LYS SEQRES 17 L 215 SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 218 ASP VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 H 218 PRO SER GLN SER LEU SER LEU THR CYS THR VAL THR GLY SEQRES 3 H 218 TYR SER ILE THR SER GLY TYR ALA TRP ASN TRP ILE ARG SEQRES 4 H 218 GLN PHE PRO GLY ASN LYS LEU GLU TRP MET GLY TYR ILE SEQRES 5 H 218 ARG TYR SER GLY ASP THR ARG TYR ASN PRO SER LEU LYS SEQRES 6 H 218 SER ARG ILE SER ILE THR ARG ASP THR SER LYS ASN GLN SEQRES 7 H 218 PHE PHE LEU GLN LEU ASN SER VAL THR THR GLU ASP THR SEQRES 8 H 218 ALA THR TYR TYR CYS ALA ILE GLY TYR GLY ASN SER ASP SEQRES 9 H 218 TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER ALA ALA SEQRES 10 H 218 LYS THR THR PRO PRO SER VAL TYR PRO LEU ALA PRO GLY SEQRES 11 H 218 CYS GLY ASP THR THR GLY SER SER VAL THR LEU GLY CYS SEQRES 12 H 218 LEU VAL LYS GLY TYR PHE PRO GLU SER VAL THR VAL THR SEQRES 13 H 218 TRP ASN SER GLY SER LEU SER SER SER VAL HIS ALA PHE SEQRES 14 H 218 PRO ALA LEU LEU GLN SER ASP LEU TYR THR MET SER SER SEQRES 15 H 218 SER VAL THR VAL PRO SER SER THR TRP PRO SER GLN THR SEQRES 16 H 218 VAL THR CYS SER VAL ALA HIS PRO ALA SER SER THR THR SEQRES 17 H 218 VAL ASP LYS LYS LEU GLU PRO LYS ASP CYS HET CD L1001 1 HET CD H1000 1 HET HAZ H 800 33 HETNAM CD CADMIUM ION HETNAM HAZ 4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA- HETNAM 2 HAZ CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]- HETNAM 3 HAZ PHENYLCARBAMOYL}-BUTYRIC ACID FORMUL 3 CD 2(CD 2+) FORMUL 5 HAZ C24 H33 N3 O6 FORMUL 6 HOH *11(H2 O) HELIX 1 1 SER L 30 TYR L 32 5 3 HELIX 2 2 ALA L 80 ASP L 82 5 3 HELIX 3 3 SER L 122 SER L 127 1 6 HELIX 4 4 LYS L 183 TYR L 186 1 4 HELIX 5 5 THR H 84 ASP H 86 5 3 HELIX 6 6 ASN H 155 GLY H 157 5 3 HELIX 7 7 PRO H 200 SER H 202 5 3 SHEET 1 A 4 LEU L 4 SER L 7 0 SHEET 2 A 4 VAL L 19 ALA L 25 -1 N SER L 24 O THR L 5 SHEET 3 A 4 SER L 70 ILE L 75 -1 N ILE L 75 O VAL L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O SER L 70 SHEET 1 B 2 ILE L 10 VAL L 13 0 SHEET 2 B 2 LYS L 103 LEU L 106 1 N LYS L 103 O MET L 11 SHEET 1 C 3 SER L 85 GLN L 90 0 SHEET 2 C 3 VAL L 33 GLN L 38 -1 N GLN L 38 O SER L 85 SHEET 3 C 3 LYS L 45 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 ASN L 137 -1 N ASN L 137 O THR L 114 SHEET 3 D 4 MET L 175 THR L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 D 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 E 3 ASN L 145 ILE L 150 0 SHEET 2 E 3 SER L 191 THR L 197 -1 N THR L 197 O ASN L 145 SHEET 3 E 3 ILE L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 F 4 GLN H 3 SER H 7 0 SHEET 2 F 4 LEU H 18 THR H 25 -1 N THR H 25 O GLN H 3 SHEET 3 F 4 GLN H 77 LEU H 82 -1 N LEU H 82 O LEU H 18 SHEET 4 F 4 ILE H 67 ASP H 72 -1 N ASP H 72 O GLN H 77 SHEET 1 G 5 THR H 107 VAL H 109 0 SHEET 2 G 5 ALA H 88 ALA H 93 -1 N TYR H 90 O THR H 107 SHEET 3 G 5 ALA H 34 GLN H 39 -1 N GLN H 39 O THR H 89 SHEET 4 G 5 LEU H 45 ARG H 52 -1 N ILE H 51 O TRP H 35 SHEET 5 G 5 THR H 57 TYR H 59 -1 N ARG H 58 O TYR H 50 SHEET 1 H 2 ALA H 93 TYR H 96 0 SHEET 2 H 2 SER H 99 TRP H 103 -1 N TYR H 102 O ILE H 94 SHEET 1 I 4 SER H 120 LEU H 124 0 SHEET 2 I 4 SER H 135 TYR H 145 -1 N LYS H 143 O SER H 120 SHEET 3 I 4 TYR H 175 PRO H 184 -1 N VAL H 183 O VAL H 136 SHEET 4 I 4 VAL H 163 PHE H 166 -1 N PHE H 166 O SER H 178 SHEET 1 J 3 THR H 151 TRP H 154 0 SHEET 2 J 3 THR H 194 HIS H 199 -1 N ALA H 198 O THR H 151 SHEET 3 J 3 THR H 204 LYS H 209 -1 N LYS H 208 O CYS H 195 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.02 SSBOND 3 CYS L 214 CYS H 128 1555 1555 2.04 SSBOND 4 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 5 CYS H 140 CYS H 195 1555 1555 2.03 LINK OE2 GLU L 81 CD CD H1000 4556 1555 2.17 LINK OE1 GLU L 187 CD CD L1001 1555 1555 2.14 LINK OE2 GLU L 213 CD CD L1001 1555 1555 2.46 LINK OE1 GLU L 213 CD CD L1001 1555 1555 2.65 LINK OD2 ASP H 173 CD CD H1000 1555 1555 2.61 LINK OD1 ASP H 173 CD CD H1000 1555 1555 2.71 CISPEP 1 SER L 7 PRO L 8 0 -0.38 CISPEP 2 PHE L 94 PRO L 95 0 0.07 CISPEP 3 TYR L 140 PRO L 141 0 0.22 CISPEP 4 PHE H 146 PRO H 147 0 -0.27 CISPEP 5 TRP H 188 PRO H 189 0 0.44 SITE 1 DC1 1 CD H1000 SITE 1 DC2 1 CD L1001 SITE 1 AC1 2 ASP H 173 GLU L 81 SITE 1 AC2 2 GLU L 187 GLU L 213 SITE 1 AC3 15 GLY H 32 TYR H 33 ALA H 34 ASN H 35A SITE 2 AC3 15 ILE H 37 ILE H 94 GLY H 95 TRP H 103 SITE 3 AC3 15 LYS H 213 ASP H 214 HOH H1103 TYR L 36 SITE 4 AC3 15 TRP L 91 TYR L 96 CYS L 214 CRYST1 101.300 70.300 69.600 90.00 114.20 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009872 0.000000 0.004436 0.00000 SCALE2 0.000000 0.014225 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015752 0.00000